Envigo augments drug development de-risking program
Envigo has launched an integrated program of in vitro technologies that help predict the likelihood of compounds causing drug induced livery injury (DILI) as part of its new De-Risking Program.
Archives for November 16, 2016
DISPATCHES FROM AAPS 2006
Excipient database: all systems go as US FDA clears backlog
The US FDA has almost cleared a backlog of 4000 excipient formulations in its Inactive Ingredient Database (IID) and wants drugmakers to help ensure ongoing accuracy.
AAPS 2016
Adaptive trial designs a 'prospectively planned opportunity,' says BMS
The most successful adaptive design trials are “designed by nature,” said BMS at the AAPS annual meeting and exposition this week in Denver, Colorado.